Abstract:Peri-implant osteolysis (PIO) and the following aseptic loosening is the leading cause of implant failure. Emerging evidence suggests that receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclast formation and osteoclastic bone resorption are responsible for particle-stimulated PIO. Here, we explored the effect of theaflavin-3,3'-digallate (TF3) on titanium particle-induced osteolysis in vivo and in vitro. Twenty-eight male C57BL/6 mice were randomly separated into four groups: sham control (sham), titanium particles only (titanium), titanium particles with low TF3 concentration (low-TF3, 1mg/kg TF3), and titanium particles with high TF3 concentration (high-TF3, 10mg/kg TF3). Two weeks later, micro-computed tomography and histological analysis were performed. Bone-marrow-derived macrophages and RAW264.7 murine macrophages were applied to examine osteoclast formation and differentiation. TF3 significantly inhibited titanium particle-induced osteolysis and prevented bone destruction compared with titanium group. Interestingly, the number of mature osteoclasts reduced after treatment with TF3 in vivo, suggesting osteoclast formation might be inhibited by TF3. In vitro, TF3 suppressed osteoclast formation, polarization and osteoclastic bone resorption by specifically targeting the RANKL-induced ERK signal pathway. Collectively, these results suggest that TF3, a natural active compound derived from black tea, is a promising candidate for the treatment of osteoclast-related osteolytic diseases, such as wear debris-induced PIO.Total joint arthroplasty is widely accepted for the treatment of end-stage joint diseases. However, it is reported that aseptic loosening, initiated by peri-implant osteolysis, is the major reason for prosthesis failure. Although the pathophysiology of PIO remains unclear, increasing evidence indicates that osteoclasts are excessively activated at the implant site by wear debris from materials. Here, we demonstrated that theaflavin-3,3'-digallate, a natural active compound derived from black tea, inhibited osteoclast formation and osteoclastic bone resorption mainly via suppressing the ERK pathway. Moreover, the findings of this study have confirmed for the first time that theaflavin-3,3'-digallate has a protective effect on particle-induced osteolysis in a mouse calvarial model, thus preventing bone loss. These results indicate that theaflavin-3,3'-digallate may be a suitable therapeutic agent to treat wear debris-induced peri-implant osteolysis.

Naringin Inhibits Titanium Particles-Induced Up-Regulation of TNF-α and IL-6 Via the P38 MAPK Pathway in Fibroblasts from Hip Periprosthetic Membrane.

The Inhibition of RANKL-Induced Osteoclastogenesis Through the Suppression of P38 Signaling Pathway by Naringenin and Attenuation of Titanium-Particle-Induced Osteolysis

Naringin Increases Osteoprotegerin Expression in Fibroblasts from Periprosthetic Membrane by the Wnt/β-catenin Signaling Pathway.

Is there another possible approach to inhibit wear particles-induced inflammatory osteolysis?

Inhibiting wear particles-induced osteolysis with naringin

Fibroblast-Like-Synoviocytes Mediate Secretion of Pro-Inflammatory Cytokines via ERK and JNK MAPKs in Ti-Particle-Induced Osteolysis

Inhibitory effects of norcantharidin on titanium particle-induced osteolysis, osteoclast activation and bone resorption via MAPK pathways

Naringenin Attenuates Inflammation and Apoptosis of Osteoarthritic Chondrocytes Via the TLR4/TRAF6/NF-κB Pathway

Effects of NF-κB Inhibitor on Titanium Particulate-Induced Inflammation in a Murine Model

Puerarin Inhibits Titanium Particle‐induced Osteolysis and RANKL‐induced Osteoclastogenesis Via Suppression of the NF‐κB Signaling Pathway

Inhibition of the PI3K/AKT pathway reduces tumor necrosis factor-alpha production in the cellular response to wear particles in vitro.

Naringin exerts antibacterial and anti‐inflammatory effects on mice with Staphylococcus aureus–induced osteomyelitis

Naringin Protects Against Cartilage Destruction in Osteoarthritis Through Repression of NF-κB Signaling Pathway

Forsythiaside inhibited titanium particle-induced inflammation via the NF-κB signaling pathway and RANKL-induced osteoclastogenesis and titanium particle-induced periprosthetic osteolysis via JNK, p38, and ERK signaling pathways

Inhibition of P38 Mitogen-Activated Protein Kinase Down-regulates the Inflammatory Osteolysis Response to Titanium Particles in a Murine Osteolysis Model

Titanium particles up-regulate the activity of matrix metalloproteinase-2 in human synovial cells

Transforming Growth Factor-Beta Activated Kinase 1 Signaling Pathways Regulate Tnf-Alpha Production by Titanium Alloy Particles in Raw 264.7 Cells

TAK1-MAPK-NFkappaB Signaling Pathways Regulates Induction of TNF-alpha by Wear Particles In Vitro

Wear particles promote reactive oxygen species-mediated inflammation via the nicotinamide adenine dinucleotide phosphate oxidase pathway in macrophages surrounding loosened implants.

Theaflavin-3,3′-digallate Represses Osteoclastogenesis and Prevents Wear Debris-Induced Osteolysis Via Suppression of ERK Pathway

Crocin Inhibits Titanium Particle-Induced Inflammation and Promotes Osteogenesis by Regulating Macrophage Polarization.